A study in humans demonstrated that hsa-miR-618 was upregulated in the peripheral blood of severely injured patients in hemorrhagic shock, showing a 7.3-fold increase compared to healthy controls upon initial measurement and remaining elevated at 24 and 48 hours after ICU admission [Galbraith et al. DOI:10.1016/j.surg.2018.05.042]. In a separate human study on sepsis, hsa-miR-618 was identified as part of a competing endogenous RNA regulatory network, where it was computationally predicted to interact with the mRNA of core prognostic genes IL2RB and TGFBR3 [Zhang et al. DOI:10.1186/s12920-023-01460-8].